Ethiopia vs Madagascar: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Ethiopia
0.6%
in 2024
Madagascar
0.6%
in 2024
Ethiopia rank
50th
Madagascar rank
50th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Ethiopia
- Madagascar
How they compare
Ethiopia currently reports 0.6% against 0.6% in Madagascar, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Ethiopia ahead.
Ethiopia ranks 50th and Madagascar ranks 50th of 215 countries.
Ethiopia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ethiopia | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.2% | 0.6% | 0.5% | Ethiopia |
| 2020s | 0.7% | 0.5% | 0.1% | Ethiopia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Ethiopia or Madagascar?
- Ethiopia, at 0.6% against 0.6% in Madagascar as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Ethiopia and Madagascar?
- 0.0%, with Ethiopia ahead.
- How many years of comparable data are there for Ethiopia and Madagascar?
- 10 years are reported by both, from 2015 to 2024.
- How do Ethiopia and Madagascar rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Ethiopia ranks 50th and Madagascar ranks 50th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.